HSA Product

RANFUZOSIN MODIFIED RELEASE TABLETS 10MG

Product approved by Health Sciences Authority (SG)

Basic Information

Product Name

RANFUZOSIN MODIFIED RELEASE TABLETS 10MG

Dosage Form

TABLET, EXTENDED RELEASE

Regulatory Information

Approval Number

SIN13984P

Approval Date

July 5, 2011

Forensic Classification

Prescription Only

Drug Type

Therapeutic

Route of Administration

ORAL

Record Created

August 10, 2023

Last Updated

May 30, 2025

ATC Business ID

XG04CA01

Company Information

ManufacturerSUN PHARMACEUTICAL INDUSTRIES LIMITED

Registrant

RANBAXY (MALAYSIA) SDN. BHD.

Licence Holder

RANBAXY (MALAYSIA) SDN. BHD.

Active Ingredients

ALFUZOSIN HYDROCHLORIDE

Strength: 10mg

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy